No Detail Found!

Clinical evaluation of herbal coded formulation cranadvantage to urixin in the treatment of urinary tract infection.

Author(s)
Ghazala Shaheen University College of Conventional Medicine, The Islamia University of Bahawalpur, Pakistan
Khan Usmanghani Faculty of Eastern Medicine, Hamdard University, Karachi, Pakistan
Halima Nazar Faculty of Eastern Medicine, Hamdard University, Karachi, Pakistan
Naveed Akhtar University College of Conventional Medicine, The Islamia University of Bahawalpur, Pakistan
Abstract
Urinary Tract Infections are the largest group of infections after the respiratory tract infections. In 85% of the cases the causative organism is E. Coli. A clinical trial was conducted to evaluate the efficacy of coded herbal formulation “CranAdvantage” (Test drug) for the treatment of Urinary tract infection comparing with Urixin (Control). One hundred and thirty patients suffering from Urinary tract infection from both groups (Males: 45, mean age: 34±14 and females: 85, mean age: 33±13 year, range: 15-55) were enrolled in the trial and divided in to two groups according to treatment regimens. CranAdvantage (Test drug) 500mg two capsules and Urixin (Pipemidic Acid Trihydrate JP15) (Control) 400mg capsules twice daily were prescribed for 2-3 weeks. Urinary tract infection was improved in 23 (35.38%) patients out of 65 patients by the use of CranAdvantage (Test drug), and in 15 (23.07%) patients out of 65 by the use of Urixin (Control drug). Furthermore, there was a significant improvement in Urinary tract infection associated clinical features as compared to Urixin. It is concluded that CranAdvantage possesses a therapeutic value for the improvement of urinary tract infection and its associated symptoms as compared to Urixin.
Publication Details
Page(s) 557-559
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 28, Issue: 2, Year: 2015

Request the full text from PASTIC

0

Citations

0

Downloads

75

Views